Login / Signup

Oral rehydration therapy versus intravenous rehydration therapy in the first 12 h following hospitalization for hyperemesis gravidarum: A randomized controlled trial.

Wan Nurul Ezyani Wan JabarudinVallikkannu NarayananMukhri HamdanYogeeta GunasagranRudra Devi ThavarajanMaherah KamarudinPeng Chiong Tan
Published in: International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics (2024)
The present study was registered in ISRCTN registry on December 6, 2020 with trial identification number: ISRCTN 40152556 (https://doi.org/10.1186/ISRCTN40152556). The first participant was recruited on February 10, 2021.
Keyphrases
  • clinical trial
  • study protocol
  • high dose
  • randomized controlled trial
  • low dose
  • mesenchymal stem cells